For the Inventor, By the Inventor

Enter inventor name

West Lafayette, IN, United States of America

G Patrick Stahly

USPTO Granted Patents = 19 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 36(Granted Patents)

Company Filing History:

Celgene Corporation

Bionevia Pharmaceuticals, Inc.

The Broad Institute, Inc.

6. 1 out of 2,656

Purdue Research Foundation

Miravant Pharmaceuticals, Inc.

8. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

Loading Chart...

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11406629 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2022-08-09),

2. 10835522 - Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2020-11-17),

3. 10464912 - Choline cocrystal of epalrestat (2019-11-05),

4. 10376503 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2019-08-13),

5. 9974780 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2018-05-22),

6. 9968627 - Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof (2018-05-15),

7. 9808450 - Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof (2017-11-07),

8. 9695146 - Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (2017-07-04),

9. 9611234 - Choline cocrystal of epalrestat (2017-04-04),

10. 9447056 - Solid forms of epalrestat (2016-09-20),

11. 9266822 - Solid forms of tacedinaline (2016-02-23),

12. 8906948 - Choline cocrystal of epalrestat (2014-12-09),

13. 8729130 - Methods of using novel solid forms of tacedinaline (2014-05-20),

14. 8697735 - Solid forms of epalrestat (2014-04-15),

15. 8691875 - Solid forms of tacedinaline (2014-04-08),

Title: G Patrick Stahly: A Pioneer in Pharmaceutical Innovations

Introduction

G Patrick Stahly is an accomplished inventor based in West Lafayette, IN, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio comprising 19 patents, he has been instrumental in developing innovative solid forms utilized in various medical applications.

Latest Patents

Among his latest patents, Stahly has developed novel solid forms including 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer. These patents focus on pharmaceutical compositions that incorporate these solid forms, which are particularly effective in treating, preventing, and managing a range of disorders. The cocrystals he has engineered enhance the performance of pharmaceutical products by improving their solubility and bioavailability.

Career Highlights

Stahly has previously worked with notable companies such as Celgene Corporation and Bionevia Pharmaceuticals, Inc. His career has been marked by a commitment to advancing pharmaceutical sciences, leading to breakthroughs in medication formulations and therapeutic applications.

Collaborations

Throughout his career, Stahly has collaborated with key figures in the industry, including David Thomas Jonaitis and Ho-Wah Hui. These partnerships have fostered innovation by combining expertise across diverse areas of pharmaceutical research and development.

Conclusion

G Patrick Stahly's contributions to the field of pharmaceuticals through his inventions and patents continue to influence medical advancements. His work not only demonstrates innovative thinking but also underscores the importance of collaboration in achieving groundbreaking results in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…